ICD 9 Range DISEASES OF OTHER ENDOCRINE GLANDS

• 1  Secondary diabetes mellitus     ( 249 )

• 2  Secondary diabetes mellitus without mention of complication     ( 249.0 )

• 3  Secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified     ( 249.00 )

• 4  Secondary diabetes mellitus without mention of complication, uncontrolled     ( 249.01 )

• 5  Secondary diabetes mellitus with ketoacidosis     ( 249.1 )

• 6  Secondary diabetes mellitus with ketoacidosis, not stated as uncontrolled, or unspecified     ( 249.10 )

• 7  Secondary diabetes mellitus with ketoacidosis, uncontrolled     ( 249.11 )

• 8  Secondary diabetes mellitus with hyperosmolarity     ( 249.2 )

• 9  Secondary diabetes mellitus with hyperosmolarity, not stated as uncontrolled, or unspecified     ( 249.20 )

• 10  Secondary diabetes mellitus with hyperosmolarity, uncontrolled     ( 249.21 )

• 11  Secondary diabetes mellitus with other coma     ( 249.3 )

• 12  Secondary diabetes mellitus with other coma, not stated as uncontrolled, or unspecified     ( 249.30 )

• 13  Secondary diabetes mellitus with other coma, uncontrolled     ( 249.31 )

• 14  Secondary diabetes mellitus with renal manifestations     ( 249.4 )

• 15  Secondary diabetes mellitus with renal manifestations, not stated as uncontrolled, or unspecified     ( 249.40 )

• 16  Secondary diabetes mellitus with renal manifestations, uncontrolled     ( 249.41 )

• 17  Secondary diabetes mellitus with ophthalmic manifestation     ( 249.5 )

• 18  Secondary diabetes mellitus with ophthalmic manifestations, not stated as uncontrolled, or unspecified     ( 249.50 )

• 19  Secondary diabetes mellitus with ophthalmic manifestations, uncontrolled     ( 249.51 )

• 20  Secondary diabetes mellitus with neurological manifestation     ( 249.6 )

• 21  Secondary diabetes mellitus with neurological manifestations, not stated as uncontrolled, or unspecified     ( 249.60 )

• 22  Secondary diabetes mellitus with neurological manifestations, uncontrolled     ( 249.61 )

• 23  Secondary diabetes mellitus with peripheral circulatory manifestation     ( 249.7 )

• 24  Secondary diabetes mellitus with peripheral circulatory disorders, not stated as uncontrolled, or unspecified     ( 249.70 )

• 25  Secondary diabetes mellitus with peripheral circulatory disorders, uncontrolled     ( 249.71 )

• 26  Secondary diabetes mellitus with other specified manifestation     ( 249.8 )

• 27  Secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified     ( 249.80 )

• 28  Secondary diabetes mellitus with other specified manifestations, uncontrolled     ( 249.81 )

• 29  Secondary diabetes mellitus with unspecified complication     ( 249.9 )

• 30  Secondary diabetes mellitus with unspecified complication, not stated as uncontrolled, or unspecified     ( 249.90 )

• 31  Secondary diabetes mellitus with unspecified complication, uncontrolled     ( 249.91 )

• 32  Diabetes mellitus     ( 250 )

• 33  Diabetes mellitus without mention of complication     ( 250.0 )

• 34  Diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled     ( 250.00 )

• 35  Diabetes mellitus without mention of complication, type i [juvenile type], not stated as uncontrolled     ( 250.01 )

• 36  Diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled     ( 250.02 )

• 37  Diabetes mellitus without mention of complication, type i [juvenile type], uncontrolled     ( 250.03 )

• 38  Diabetes with ketoacidosis     ( 250.1 )

• 39  Diabetes with ketoacidosis, type ii or unspecified type, not stated as uncontrolled     ( 250.10 )

• 40  Diabetes with ketoacidosis, type i [juvenile type], not stated as uncontrolled     ( 250.11 )

• 41  Diabetes mellitus with ketoacidosis type ii or unspecified type uncontrolled     ( 250.12 )

• 42  Diabetes with ketoacidosis, type i [juvenile type], uncontrolled     ( 250.13 )

• 43  Diabetes with hyperosmolarity     ( 250.2 )

• 44  Diabetes with hyperosmolarity, type ii or unspecified type, not stated as uncontrolled     ( 250.20 )

• 45  Diabetes with hyperosmolarity, type i [juvenile type], not stated as uncontrolled     ( 250.21 )

• 46  Diabetes with hyperosmolarity, type ii or unspecified type, uncontrolled     ( 250.22 )

• 47  Diabetes with hyperosmolarity, type i [juvenile type], uncontrolled     ( 250.23 )

• 48  Diabetes with other coma     ( 250.3 )

• 49  Diabetes with other coma, type ii or unspecified type, not stated as uncontrolled     ( 250.30 )

• 50  Diabetes with other coma, type i [juvenile type], not stated as uncontrolled     ( 250.31 )

• 51  Diabetes with other coma, type ii or unspecified type, uncontrolled     ( 250.32 )

• 52  Diabetes with other coma, type i [juvenile type], uncontrolled     ( 250.33 )

• 53  Diabetes with renal manifestations     ( 250.4 )

• 54  Diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled     ( 250.40 )

• 55  Diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled     ( 250.41 )

• 56  Diabetes with renal manifestations, type ii or unspecified type, uncontrolled     ( 250.42 )

• 57  Diabetes with renal manifestations, type i [juvenile type], uncontrolled     ( 250.43 )

• 58  Diabetes with ophthalmic manifestations     ( 250.5 )

• 59  Diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled     ( 250.50 )

• 60  Diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled     ( 250.51 )

• 61  Diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled     ( 250.52 )

• 62  Diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled     ( 250.53 )

• 63  Diabetes with neurological manifestations     ( 250.6 )

• 64  Diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled     ( 250.60 )

• 65  Diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled     ( 250.61 )

• 66  Diabetes with neurological manifestations, type ii or unspecified type, uncontrolled     ( 250.62 )

• 67  Diabetes with neurological manifestations, type i [juvenile type], uncontrolled     ( 250.63 )

• 68  Diabetes with peripheral circulatory disorders     ( 250.7 )

• 69  Diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled     ( 250.70 )

• 70  Diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled     ( 250.71 )

• 71  Diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled     ( 250.72 )

• 72  Diabetes with peripheral circulatory disorders, type i [juvenile type], uncontrolled     ( 250.73 )

• 73  Diabetes with other specified manifestations     ( 250.8 )

• 74  Diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled     ( 250.80 )

• 75  Diabetes with other specified manifestations, type i [juvenile type], not stated as uncontrolled     ( 250.81 )

• 76  Diabetes with other specified manifestations, type ii or unspecified type, uncontrolled     ( 250.82 )

• 77  Diabetes with other specified manifestations, type i [juvenile type], uncontrolled     ( 250.83 )

• 78  Diabetes with unspecified complication     ( 250.9 )

• 79  Diabetes with unspecified complication, type ii or unspecified type, not stated as uncontrolled     ( 250.90 )

• 80  Diabetes with unspecified complication, type i [juvenile type], not stated as uncontrolled     ( 250.91 )

• 81  Diabetes with unspecified complication, type ii or unspecified type, uncontrolled     ( 250.92 )

• 82  Diabetes with unspecified complication, type i [juvenile type], uncontrolled     ( 250.93 )

• 83  Other disorders of pancreatic internal secretion     ( 251 )

• 84  Hypoglycemic coma     ( 251.0 )

• 85  Other specified hypoglycemia     ( 251.1 )

• 86  Hypoglycemia unspecified     ( 251.2 )

• 87  Postsurgical hypoinsulinemia     ( 251.3 )

• 88  Abnormality of secretion of glucagon     ( 251.4 )

• 89  Abnormality of secretion of gastrin     ( 251.5 )

• 90  Other specified disorders of pancreatic internal secretion     ( 251.8 )

• 91  Unspecified disorder of pancreatic internal secretion     ( 251.9 )

• 92  Disorders of parathyroid gland     ( 252 )

• 93  Hyperparathyroidism     ( 252.0 )

• 94  Hyperparathyroidism, unspecified     ( 252.00 )

• 95  Primary hyperparathyroidism     ( 252.01 )

• 96  Secondary hyperparathyroidism, non-renal     ( 252.02 )

• 97  Other hyperparathyroidism     ( 252.08 )

• 98  Hypoparathyroidism     ( 252.1 )

• 99  Other specified disorders of parathyroid gland     ( 252.8 )

• 100  Unspecified disorder of parathyroid gland     ( 252.9 )

• 101  Disorders of the pituitary gland and its hypothalamic control     ( 253 )

• 102  Acromegaly and gigantism     ( 253.0 )

• 103  Other and unspecified anterior pituitary hyperfunction     ( 253.1 )

• 104  Panhypopituitarism     ( 253.2 )

• 105  Pituitary dwarfism     ( 253.3 )

• 106  Other anterior pituitary disorders     ( 253.4 )

• 107  Diabetes insipidus     ( 253.5 )

• 108  Other disorders of neurohypophysis     ( 253.6 )

• 109  Iatrogenic pituitary disorders     ( 253.7 )

• 110  Other disorders of the pituitary and other syndromes of diencephalohypophyseal origin     ( 253.8 )

• 111  Unspecified disorder of the pituitary gland and its hypothalamic control     ( 253.9 )

• 112  Diseases of thymus gland     ( 254 )

• 113  Persistent hyperplasia of thymus     ( 254.0 )

• 114  Abscess of thymus     ( 254.1 )

• 115  Other specified diseases of thymus gland     ( 254.8 )

• 116  Unspecified disease of thymus gland     ( 254.9 )

• 117  Disorders of adrenal glands     ( 255 )

• 118  Cushing's syndrome     ( 255.0 )

• 119  Hyperaldosteronism     ( 255.1 )

• 120  Hyperaldosteronism, unspecified     ( 255.10 )

• 121  Glucocorticoid-remediable aldosteronism     ( 255.11 )

• 122  Conn's syndrome     ( 255.12 )

• 123  Bartter's syndrome     ( 255.13 )

• 124  Other secondary aldosteronism     ( 255.14 )

• 125  Adrenogenital disorders     ( 255.2 )

• 126  Other corticoadrenal overactivity     ( 255.3 )

• 127  Corticoadrenal insufficiency     ( 255.4 )

• 128  Glucocorticoid deficiency     ( 255.41 )

• 129  Mineralocorticoid deficiency     ( 255.42 )

• 130  Other adrenal hypofunction     ( 255.5 )

• 131  Medulloadrenal hyperfunction     ( 255.6 )

• 132  Other specified disorders of adrenal glands     ( 255.8 )

• 133  Unspecified disorder of adrenal glands     ( 255.9 )

• 134  Ovarian dysfunction     ( 256 )

• 135  Hyperestrogenism     ( 256.0 )

• 136  Other ovarian hyperfunction     ( 256.1 )

• 137  Postablative ovarian failure     ( 256.2 )

• 138  Other ovarian failure     ( 256.3 )

• 139  Premature menopause     ( 256.31 )

• 140  Other ovarian failure     ( 256.39 )

• 141  Polycystic ovaries     ( 256.4 )

• 142  Other ovarian dysfunction     ( 256.8 )

• 143  Unspecified ovarian dysfunction     ( 256.9 )

• 144  Testicular dysfunction     ( 257 )

• 145  Testicular hyperfunction     ( 257.0 )

• 146  Postablative testicular hypofunction     ( 257.1 )

• 147  Other testicular hypofunction     ( 257.2 )

• 148  Other testicular dysfunction     ( 257.8 )

• 149  Unspecified testicular dysfunction     ( 257.9 )

• 150  Polyglandular dysfunction and related disorders     ( 258 )

• 151  Polyglandular activity in multiple endocrine adenomatosis     ( 258.0 )

• 152   Multiple endocrine neoplasia [MEN] type I     ( 258.01 )

• 153   Multiple endocrine neoplasia [MEN] type IIA     ( 258.02 )

• 154   Multiple endocrine neoplasia [MEN] type IIB     ( 258.03 )

• 155  Other combinations of endocrine dysfunction     ( 258.1 )

• 156  Other specified polyglandular dysfunction     ( 258.8 )

• 157  Polyglandular dysfunction unspecified     ( 258.9 )

• 158  Other endocrine disorders     ( 259 )

• 159  Delay in sexual development and puberty not elsewhere classified     ( 259.0 )

• 160  Precocious sexual development and puberty not elsewhere classified     ( 259.1 )

• 161  Carcinoid syndrome     ( 259.2 )

• 162  Ectopic hormone secretion not elsewhere classified     ( 259.3 )

• 163  Dwarfism not elsewhere classified     ( 259.4 )

• 164  Androgen insensitivity syndrome     ( 259.5 )

• 165  Androgen insensitivity, unspecified     ( 259.50 )

• 166  Androgen insensitivity syndrome     ( 259.51 )

• 167  Partial androgen insensitivity     ( 259.52 )

• 168  Other specified endocrine disorders     ( 259.8 )

• 169  Unspecified endocrine disorder     ( 259.9 )